Kimberly-Clark’s $50 billion offer for Kenvue signals a move into new categories like skin care and pain relief, but investors are wary. The deal aims to drive growth through new product introductions. Talks began after Kenvue’s CEO left, and Kimberly-Clark expects $2.1 billion in cost savings annually.

Analysts express skepticism over the Kimberly-Clark-Kenvue merger, citing questionable strategic fit and concerns over consumer buying power. Rival Procter & Gamble was also rumored as a suitor. Kimberly-Clark eyes international markets like China for growth, while Kenvue has a strong distribution network in India. Both companies face legal challenges.

Read more at Yahoo Finance: Kimberly-Clark’s $50 billion leap into health and beauty tests investor faith